Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
The food-borne infections listeriosis and shigatoxigenic Escherichia coli are increasing in the EU/EEA and were in 2022 at levels higher than before the COVID-19 pandemic.
For 2022, 29 European Union/European Economic Area (EU/EEA) countries reported 8 565 confirmed cases of Shiga toxin-producing Escherichia coli (STEC) infection.
Despite good access to effective antibiotics, Streptococcus pneumoniae (pneumococci) is still a major cause of disease and death in both developing and developed countries. Pneumococci are the main cause of bacterial respiratory tract infections, such as pneumonia, middle ear infection, and sinusitis, in all age groups.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 September 2023 and includes updates on COVID-19, diphtheria, West Nile virus, avian influenza, dengue, legionnaires' disease, the Rugby World Cup 2023, cutaneous Anthrax, pertussis, botulism and severe floods.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20-26 August and includes updates on avian influenza, botulism, autochthonous dengue, Legionnaires' disease, COVID-19, West Nile virus, Chikungunya and dengue.
This report is based on data for 2021 retrieved from The European Surveillance System (TESSy) on 9 October 2022. TESSy, hosted at ECDC, is a system for the collection, analysis and dissemination of data on communicable diseases.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 July - 5 August 2023 and includes updates on avian influenza, botulism, echovirus, West Nile virus, COVID-19, and Crimean-Congo haemorrhagic fever.